Ustekinumab in adolescent patients age 12 to 17 years with moderate-to-severe plaque psoriasis: Results of the randomized phase 3 CADMUS study

作者: Ian Landells , Colleen Marano , Ming-Chun Hsu , Shu Li , Yaowei Zhu

DOI: 10.1016/J.JAAD.2015.07.002

关键词:

摘要: Background Safe and effective therapies are needed for pediatric patients with psoriasis. Objective The purpose of this study was to evaluate ustekinumab in patients age 12 to 17 years …

参考文章(14)
Alan Menter, Neil J. Korman, Craig A. Elmets, Steven R. Feldman, Joel M. Gelfand, Kenneth B. Gordon, Alice Gottlieb, John Y.M. Koo, Mark Lebwohl, Craig L. Leonardi, Henry W. Lim, Abby S. Van Voorhees, Karl R. Beutner, Caitriona Ryan, Reva Bhushan, Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions. Journal of The American Academy of Dermatology. ,vol. 65, pp. 137- 174 ,(2011) , 10.1016/J.JAAD.2010.11.055
KA1 Papp, CEM Griffiths, K Gordon, M Lebwohl, PO Szapary, Y Wasfi, D Chan, M‐C Hsu, V Ho, Pierre-Dominique Ghislain, B Strober, K Reich, PHOENIX 1, PHOENIX 2 and ACCEPT Investigators, Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up. British Journal of Dermatology. ,vol. 168, pp. 844- 854 ,(2013) , 10.1111/BJD.12214
Stuart J. Pocock, Richard Simon, Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial Biometrics. ,vol. 31, pp. 103- 115 ,(1975) , 10.2307/2529712
Yaowei Zhu, Chuanpu Hu, Ming Lu, Sam Liao, Joseph C. Marini, Jennifer Yohrling, Newman Yeilding, Hugh M. Davis, Honghui Zhou, Population Pharmacokinetic Modeling of Ustekinumab, a Human Monoclonal Antibody Targeting IL-12/23p40, in Patients With Moderate to Severe Plaque Psoriasis The Journal of Clinical Pharmacology. ,vol. 49, pp. 162- 175 ,(2009) , 10.1177/0091270008329556
M.S. LEWIS-JONES, A.Y. FINLAY, The children's dermatology life quality index (CDLQI) : initial validation and practical use British Journal of Dermatology. ,vol. 132, pp. 942- 949 ,(2010) , 10.1111/J.1365-2133.1995.TB16953.X
Christina Fotiadou, Elizabeth Lazaridou, Demetrios Ioannides, Management of psoriasis in adolescence Adolescent Health, Medicine and Therapeutics. ,vol. 5, pp. 25- 34 ,(2014) , 10.2147/AHMT.S36672
Eugene M. Farber, Lexie Nall, The natural history of psoriasis in 5,600 patients. Dermatology. ,vol. 148, pp. 1- 18 ,(1974) , 10.1159/000251595
T. Fredriksson, U. Pettersson, Severe psoriasis--oral therapy with a new retinoid. Dermatology. ,vol. 157, pp. 238- 244 ,(1978) , 10.1159/000250839
James W. Varni, Denise R. Globe, Shravanthi R. Gandra, David J. Harrison, Michele Hooper, Scott Baumgartner, Health-related quality of life of pediatric patients with moderate to severe plaque psoriasis: comparisons to four common chronic diseases European Journal of Pediatrics. ,vol. 171, pp. 485- 492 ,(2012) , 10.1007/S00431-011-1587-2
Alice Gottlieb, Neil J. Korman, Kenneth B. Gordon, Steven R. Feldman, Mark Lebwohl, John Y.M. Koo, Abby S. Van Voorhees, Craig A. Elmets, Craig L. Leonardi, Karl R. Beutner, Reva Bhushan, Alan Menter, Guidelines of care for the management of psoriasis and psoriatic arthritis Journal of the American Academy of Dermatology. ,vol. 58, pp. 851- 864 ,(2008) , 10.1016/J.JAAD.2008.02.040